• Profile

Selective serotonin reuptake inhibitors and risk of noncardioembolic ischemic stroke: A nested case-control study

Stroke Feb 08, 2022

Researchers herein aimed at evaluating the reported correlation between the use of selective serotonin reuptake inhibitors (SSRIs) and an increased risk of ischemic stroke using different approaches to minimize the potential bias.

  • In a Spanish primary health-care database, researchers conducted a nested case-control study including patients sustaining an ischemic stroke with no sign of cardioembolic or unusual cause.

  • Up to 5 matched controls (for exact age, gender, and index date) were randomly selected for each case.

  • Included were a total of 8,296 cases and 37,272 matched controls.

  • Among cases and controls, 255 (3.07%) and 834 (2.24%) individuals were current users of SSRIs, respectively.

  • Findings indicated no association of the use of SSRIs with an elevated risk of noncardioembolic ischemic stroke.

  • On the contrary, there appeared protective effects of SSRIs when compared with other antidepressants.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen